Status:
NOT_YET_RECRUITING
Digital Diagnostics and Intervention Services for Parkinson's Disease
Lead Sponsor:
University of Exeter
Collaborating Sponsors:
GaitQ company
Conditions:
Brain Diseases
Central Nervous System Diseases
Eligibility:
All Genders
18+ years
Brief Summary
People with Parkinson's have infrequent clinical consultation (once every 12-18 months) and limited rehabilitation. Assessment play an important role in these consultations to help clinicians underst...
Detailed Description
Diagnosis: The current state of the art in diagnosing PD primarily revolves around clinical assessments based on symptomatology and neurological examination. The most widely used criteria for diagnosi...
Eligibility Criteria
Inclusion
- Diagnosis of idiopathic Parkinson's disease (UK Brain Bank Criteria) or other appropriate condition specific scale \[stroke, multiple sclerosis, arthritis or osteoporosis\]
- Able to self-report history of daily gait freezing and/or festination for people with PD or gait and/or transfers affected by condition
- Able to walk unsupported or using an aid for at least 5 minutes and satisfactory completion of the Canadian PARQ and if over 69 used to carrying out this level of exercise
- Adult (+18 years old)
- Normal or corrected-to-normal vision (Snellen Visual Acuity \> 12/18) or safe to mobilise with support
- Montreal Cognitive assessment score \>21 or ability to follow 2 stage commands Healthy participants \[Phase 1,2,3\]
- With no long-term conditions affecting movement
- Able to walk unsupported or using an aid for at least 3 minutes and satisfactory completion of the Canadian PARQ and
- if over 69 used to carrying out this level of exercise
- Adult (+18 years old)
- Normal or corrected-to-normal vision (Snellen Visual Acuity \> 12/18) or safe to mobilise with support
- Montreal Cognitive assessment score \>21 or ability to follow 2 stage commands
Exclusion
- Participants with long-term conditions affecting movement
- Any physical or mental condition affecting ability to safely participate in this level of activity and capacity to understand
- testing as demonstrated by ability to safely follow commands and pass the PARQ by the research team.
- Cognitive impairment affecting ability to safely participate and follow instructions
- Any injury or disorder that may affect balance (other than Parkinson's or referring primary condition)
- Any skin conditions or broken skin in the calf and behind knee area
- Deep brain stimulation or pacemaker implants or other implant that may interfere with the measurement system Healthy participants
- Any physical or mental condition affecting ability to safely participate in this level of activity and capacity to understand
- testing as demonstrated by ability to safely follow commands and pass the PARQ by the research team.
- Cognitive impairment affecting ability to safely participate and follow instructions
- Any injury or disorder that may affect balance (other than Parkinson's or referring primary condition)
- Any skin conditions or broken skin in the calf and behind knee area
- Deep brain stimulation or pacemaker implants or other implants that may interfere with the measurement system
Key Trial Info
Start Date :
October 15 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06534177
Start Date
October 15 2024
End Date
March 1 2026
Last Update
August 9 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.